FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

787732000: Risankizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3776694016 Risankizumab en Synonym Active Entire term case insensitive SNOMED CT core module
3776695015 Risankizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risankizumab Is a Substance with interleukin 23 receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Risankizumab Has disposition Interleukin 23 receptor antagonist true Inferred relationship Existential restriction modifier
Risankizumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Risankizumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Risankizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Risankizumab Is a Monoclonal antibody false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing risankizumab (medicinal product) Has active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing risankizumab in parenteral dose form (medicinal product form) Has active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing only risankizumab in parenteral dose form (medicinal product form) Has active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Risankizumab Has active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing precisely risankizumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Risankizumab Inferred relationship Existential restriction modifier 1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Risankizumab Inferred relationship Existential restriction modifier 1
Risankizumab 150mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Risankizumab 150mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 150mg/1ml solution for injection pre-filled pens (AbbVie Ltd) 1 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 150mg/1ml solution for injection pre-filled syringes (AbbVie Ltd) 1 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 150mg/1ml solution for injection pre-filled syringes (AbbVie Ltd) Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 150mg/1ml solution for injection pre-filled pens (AbbVie Ltd) Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Risankizumab 150mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Risankizumab 150mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Risankizumab 75mg/0.83ml solution for injection pre-filled syringes Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 75mg/0.83ml solution for injection pre-filled syringes (AbbVie Ltd) Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Risankizumab 75mg/0.83ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier
Skyrizi 75mg/0.83ml solution for injection pre-filled syringes (AbbVie Ltd) 2 pre-filled disposable injection Has specific active ingredient True Risankizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start